 |
|
Home | JPMorgan Chase Reiterates “Overweight” Rating on St. Jude Medical (STJ) |
 |
JPMorgan Chase Reiterates “Overweight” Rating on St. Jude Medical (STJ)
|
 |
- November 23, 2012
-
St. Jude Medical (NYSE: STJ)‘s stock had its “overweight” rating reiterated by investment analysts at JPMorgan Chase in a note issued to investors on Friday. They currently have a $47.00 target price on the stock. St. Jude Medical traded up 2.14% on Friday, hitting $32.04. St. Jude Medical has a 1-year low of $30.25 and [...]This article (JPMorgan Chase Reiterates “Overweight” Rating on St. Jude Medical (STJ)) was originally developed by and is property of American Banking News. Checkout American Banking News for up-to-date banking news and peer to peer lending news.
- Read more at:http://www.americanbankingnews.com/2012/11/23/jpmorgan-chase-reiterates-overweight-rating-on-st-jude-medical-stj/
|
 |
|
 |
|
 |
